Learn More
Invitrogen™ PRAME Polyclonal Antibody

Description
Gently mix before use. Optimal concentrations and conditions for each application should be determined by the user. Immunogen sequence: VLDLRKNSHQ DFWTVWSGNR ASLYSFPEPE AAQPMTKKRK VDGLSTEAEQ PFIPVEVLVD LFLKEGACDE LFSYLIEKVK RKKNVLRLCC KKLKIFAMPM QDIKMILKMV QLDSIEDLEV TCTWKLPTL Highest antigen sequence indentity to the following orthologs: Mouse - 40%, Rat - 40%.
Specifications
Specifications
| Antigen | PRAME |
| Applications | Immunocytochemistry |
| Classification | Polyclonal |
| Concentration | 0.5 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 |
| Gene | PRAME |
| Gene Accession No. | P78395 |
| Gene Alias | 4930534P07Rik; cancer/testis antigen 130; CT130; MAPE; melanoma antigen preferentially expressed in tumors; OIP4; OIP-4; Opa-interacting protein 4; Opa-interacting protein OIP4; PRAME; preferentially expressed antigen in melanoma; preferentially expressed antigen of melanoma |
| Gene Symbols | PRAME |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.